From Misdiagnosis to Hope: Michelle Williams' Journey with IC-MPGN and the Breakthrough Treatment of Pegcetacoplan
Michelle Williams initially dismissed her high blood pressure as stress-related, but as her symptoms worsened, she sought medical help. After a disappointing visit with a nephrologist, she referred herself to the Cleveland Clinic, where she was diagnosed with multiple myeloma, a form of blood cancer that affects the kidneys. Despite undergoing chemotherapy and immunotherapy, her symptoms persisted, leading to a rare diagnosis of IC-MPGN, a kidney disease related to the immune system. This condition, affecting only a few people per million, had no known cause or effective treatment until the introduction of pegcetacoplan in clinical trials in 2025. Williams joined the trial and experienced immediate improvement in her condition, offering hope for a better outcome.